{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:26:35Z","timestamp":1777868795587,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011851","name":"Fight against Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.radonc.2025.110780","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T18:58:34Z","timestamp":1738954714000},"page":"110780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Radiotherapy quality assurance for the PEACE 1 trial: An individual case review analysis"],"prefix":"10.1016","volume":"206","author":[{"given":"Najlaa","family":"Alyamani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Clementel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Sargos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephane","family":"Supiot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Ronchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Pommier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Duberge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlon","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasser","family":"Hammoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Hasbini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Khalifa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khemara","family":"Gnep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Scrase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Saez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure","family":"Vieillevigne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Christiaens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Zilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Ribault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Fizazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolaus","family":"Andratschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.110780_b0005","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/S0140-6736(18)32486-3","article-title":"Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial","volume":"392","author":"Parker","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2025.110780_b0010","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.eururo.2018.09.008","article-title":"Effect on survival of androgen deprivation therapy alone compared to androgen deprivation therapy combined with concurrent radiation therapy to the prostate in patients with primary bone metastatic prostate cancer in a prospective randomised clinical tria","volume":"75","author":"Boev\u00e9","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.radonc.2025.110780_b0015","doi-asserted-by":"crossref","first-page":"S592","DOI":"10.21037\/tcr.2019.05.27","article-title":"Local therapy in patients with metastatic prostate cancer: a new standard of care?","volume":"8","author":"Harper","year":"2019","journal-title":"Translat Can Res."},{"key":"10.1016\/j.radonc.2025.110780_b0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.eururo.2019.02.003","article-title":"Prostate radiotherapy for metastatic hormone-sensitive prostate cancer: a STOPCAP systematic review and meta-analysis","volume":"76","author":"Burdett","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.radonc.2025.110780_b0025","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(22)00367-1","article-title":"Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2\u2009\u00d7\u20092 factorial design","volume":"399","author":"Fizazi","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2025.110780_b0030","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0140-6736(24)01865-8","article-title":"Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2\u2008\u00d7\u20082 factorial design","volume":"404","author":"Bossi","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2025.110780_b0035","doi-asserted-by":"crossref","unstructured":"Alysa Fairchild, Edwin Aird, Paul A. Fenton, Vincent Gregoire, Akos Gulyban, Denis Lacombe, Oscar Matzinger, Philip Poortmans, Pascal Ruyskart, Damien C. Weber CWH. EORTC Radiation Oncology Group quality assurance platform: Establishment of a digital central review facility. Radiotherapy Oncol. 2012;103(3): 279\u2013286.","DOI":"10.1016\/j.radonc.2012.04.015"},{"key":"10.1016\/j.radonc.2025.110780_b0040","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.radonc.2011.05.073","article-title":"Quality assurance for prospective EORTC radiation oncology trials: the challenges of advanced technology in a multicenter international setting","volume":"100","author":"Weber","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110780_b0045","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.ijrobp.2014.08.348","article-title":"Global harmonization of quality assurance naming conventions in radiation therapy clinical trials","volume":"90","author":"Melidis","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110780_b0050","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.radonc.2014.03.023","article-title":"Radiation therapy quality assurance in clinical trials - global harmonisation group","volume":"111","author":"Melidis","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110780_b0055","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1200\/JCO.2009.27.4498","article-title":"Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02","volume":"28","author":"Peters","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110780_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00792","article-title":"The impact of clinical trial quality assurance on outcome in head and neck radiotherapy treatment","volume":"9","author":"Zhong","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.110780_b0065","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0959-8049(02)00461-6","article-title":"Quality assurance in radiotherapy","volume":"39","author":"Kouloulias","year":"2003","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.radonc.2025.110780_b0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0167-8140(95)01612-K","article-title":"Quality assurance of the EORTC radiotherapy trial 22863 for prostatic cancer: the dummy run","volume":"36","author":"Dusserre","year":"1995","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110780_b0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0167-8140(02)00143-3","article-title":"Quality assurance of the EORTC trial 22911. A phase III study of post-operative external radiotherapy in pathological stage T3N0 prostatic carcinoma: the dummy run","volume":"64","author":"Davis","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110780_b0080","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.ejca.2004.07.019","article-title":"High conformality radiotherapy in Europe: Thirty-one centres participating in the quality assurance programme of the EORTC prostate trial 22991","volume":"40","author":"Ataman","year":"2004","journal-title":"Eur J Can"},{"key":"10.1016\/j.radonc.2025.110780_b0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.radonc.2004.08.005","article-title":"Quality assurance of the 22961 EORTC trial. A phase III study of the optimal combination of hormonal adjuvant treatment by LHRH analogue and radiation therapy for the management of locally advanced prostate cancer: the dummy run","volume":"73","author":"Kouloulias","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110780_b0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.radonc.2008.10.022","article-title":"Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review","volume":"90","author":"Matzinger","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110780_b0095","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.radonc.2013.04.020","article-title":"Quality assurance of the EORTC 22043-30041 trial in post-operative radiotherapy in prostate cancer: results of the dummy run procedure","volume":"107","author":"Fenton","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110780_b0100","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.110780_b0105","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.clon.2019.05.009","article-title":"Radiotherapy quality assurance for the CHHiP trial: conventional versus hypofractionated high-dose intensity-modulated radiotherapy in prostate cancer","volume":"31","author":"Naismith","year":"2019","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110780_b0110","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1200\/JCO.2016.67.0448","article-title":"Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer","volume":"34","author":"Lee","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110780_b0115","doi-asserted-by":"crossref","unstructured":"Murray JR, Tree AC, Alexander EJ, Sohaib A, Hazell S, Thomas K, et al. Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: Efficacy and Toxicity in the DELINEATE Trial. Int J Radiat Oncol Biol Phys [Internet]. 2020;106(4):715\u2013Available from: https:\/\/doi.org\/10.1016\/j.ijrobp.2019.11.402.","DOI":"10.1016\/j.ijrobp.2019.11.402"},{"key":"10.1016\/j.radonc.2025.110780_b0120","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ijrobp.2020.06.002","article-title":"Urethra-sparing stereotactic body radiation therapy for prostate cancer: quality assurance of a randomized phase 2 trial","volume":"108","author":"Jaccard","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110780_b0125","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.radonc.2008.10.022","article-title":"Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review","volume":"90","author":"Matzinger","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110780_b0130","doi-asserted-by":"crossref","unstructured":"Vandewinckele L, Claessens M, Dinkla A, Brouwer C, Crijns W, Verellen D, et al. Overview of artificial intelligence-based applications in radiotherapy: Recommendations for implementation and quality assurance. Vol. 153, Radiother Oncol. Elsevier Ireland Ltd; 2020. p. 55\u201366.","DOI":"10.1016\/j.radonc.2020.09.008"},{"key":"10.1016\/j.radonc.2025.110780_b0135","first-page":"197","article-title":"A joint ESTRO and AAPM guideline for development, clinical validation and reporting of artificial intelligence models in radiation therapy","volume":"1","author":"Hurkmans","year":"2024","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025000751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025000751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:42:16Z","timestamp":1777552936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025000751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":27,"alternative-id":["S0167814025000751"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110780","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy quality assurance for the PEACE 1 trial: An individual case review analysis","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110780","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110780"}}